What is Crescent Capital BDC, Inc.'s earnings per share (EPS)?

Crescent Capital BDC, Inc. (CCAP) reported diluted earnings per share of $1.81 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Crescent Capital BDC, Inc. (CCAP) Financials

CCAP

FY2025 annual

Revenue Not reported for FY2025

Net Income $34.5M -53.1% YoY

EPS (Diluted) $1.81 YoY not available

Operating Cash Flow $74.7M +26.8% YoY

Market Cap $364.0M as of Sep 17, 2026

Price / Sales n/m no revenue reported

Price / Earnings 10.5x on $34.5M net income, FY2025

Price / Book 0.6x on $656.5M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 10, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CCAP SEC filings page.

This page shows Crescent Capital BDC, Inc. (CCAP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CCAP FY2025 2026-08-29

Investment-driven earnings are layered onto a balance sheet that has become steadily more debt-dependent.

The company reported positive net income in every available year despite negative operating income throughout, so reported profitability is not coming from operating income alone. In FY2025, operating cash flow of $74.7M exceeded net income of $34.5M, while FY2024 showed the reverse pattern, indicating that earnings and cash generation move on different schedules rather than tracking consistently.

Debt-to-equity rose from 0.97x in FY2021 to 1.2x in FY2025, while total liabilities reached $916.1M against $706.0M of equity. That combination points to a progressively more leveraged financing structure, even though total assets were broadly stable over the latest two years.

Net income fell from $73.6M in FY2024 to $34.5M in FY2025, but operating cash flow increased from $58.9M to $74.7M. The divergence suggests that reported income includes timing or valuation effects not mirrored directly in cash, while the lower equity balance also reduced the return-on-equity measure to 0.05.

Financial Health Signals

Financial health score not available

Crescent Capital BDC, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/6

Crescent Capital BDC, Inc. passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Cash-Backed

2.17x

For every $1 of reported earnings, Crescent Capital BDC, Inc. generates $2.17 in operating cash flow ($74.7M OCF vs $34.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

N/A

Crescent Capital BDC, Inc. reported an operating loss of $98.7M against $57.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income

-$3.2M

YoY-121.6%

QoQ+79.1%

Crescent Capital BDC, Inc. reported -$3.2M in net income in Q2 2026. This represents a decrease of 121.6% from the same quarter a year earlier. Against the prior quarter it is up 79.1%.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$15.6M

YoY+60.2%

QoQ+154.2%

Crescent Capital BDC, Inc. held $15.6M in cash against $922.9M in long-term debt as of Q2 2026.

Shares Outstanding

37M

YoY-0.6%

QoQ0.0%

Crescent Capital BDC, Inc. had 37M shares outstanding in Q2 2026. This represents a decrease of 0.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity

-0.5%

YoY-2.6pp

QoQ+1.8pp

Crescent Capital BDC, Inc.'s ROE was -0.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$667K

QoQ-33.3%

Crescent Capital BDC, Inc. spent $667K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 33.3%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CCAP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CCAP quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Income	N/A	-$98.7M+7.6%	-$106.8M-6.5%	-$100.3M-76.5%	-$56.8M-28.8%	-$44.1M-65.3%	-$26.7M
Interest Expense	N/A	$57.4M-8.5%	$62.8M+6.8%	$58.7M+84.3%	$31.9M+61.3%	$19.8M+27.6%	$15.5M
Income Tax	N/A	$6K-96.1%	$155K+400.0%	$31K+109.5%	-$326K-118.8%	$1.7M+3496.1%	-$51K
Net Income	N/A	$34.5M-53.1%	$73.6M-12.2%	$83.8M+439.4%	$15.5M-81.4%	$83.6M+53.0%	$54.7M
EPS (Basic)	N/A	$1.81-24.6%	$2.40+4.3%	$2.30+19.2%	$1.93+15.6%	$1.67-7.2%	$1.80
EPS (Diluted)	—	$1.81	$2.40+4.3%	$2.30	$1.93	$1.67	$1.80
Diluted Shares (Avg)	N/A	37M	37M+3.2%	36M	31M	28M	28M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Income	-$22.7M+11.6%	-$21.9M+12.6%	N/A	-$24.1M+12.0%	-$25.7M+4.1%	-$25.0M+6.3%	N/A	-$27.4M-5.2%
Interest Expense	$14.9M-1.9%	$13.7M-6.1%	N/A	$13.9M-13.8%	$15.2M-4.9%	$14.6M-6.2%	N/A	$16.1M+4.7%
Income Tax	$25K	N/A	N/A	$0-100.0%	$0	$6K	N/A	$155K
Net Income	-$3.2M-121.6%	-$15.5M-497.4%	N/A	$7.1M-53.5%	$15.0M-26.4%	$3.9M-86.1%	N/A	$15.3M-32.5%
EPS (Basic)	N/A	$0.42-6.7%	$0.45-18.2%	$0.46-28.1%	$0.46-22.0%	$0.45-28.6%	$0.55-11.3%	$0.64+8.5%
EPS (Diluted)	N/A	$0.42-6.7%	$0.45-18.2%	$0.46	$0.46-22.0%	$0.45	$0.55-11.3%	$0.64
Diluted Shares (Avg)	37M-0.6%	37M-0.4%	N/A	37M	37M0.0%	37M	N/A	37M

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA.

CCAP Balance Sheet

CCAP quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$1.6B-2.1%	$1.7B+1.8%	$1.6B+24.9%	$1.3B-1.1%	$1.3B	N/A
Cash & Equivalents	$5.0M-50.2%	$10.1M+30.2%	$7.8M+21.6%	$6.4M-36.5%	$10.1M+476.7%	$1.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0
Total Liabilities	$916.1M+0.1%	$915.6M+3.5%	$884.8M+28.2%	$690.3M+3.7%	$665.5M	N/A
Long-Term Debt	$873.8M-0.2%	$875.8M+3.7%	$844.8M+29.1%	$654.5M+3.7%	$631.0M	N/A
Total Equity	$706.0M-4.7%	$740.6M-0.3%	$742.6M+21.2%	$612.5M-6.1%	$652.3M+16.5%	$560.0M
Retained Earnings	-$251.0M-14.9%	-$218.5M+2.2%	-$223.3M-257.4%	-$62.5M-349.4%	-$13.9M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.6B-2.1%	$1.6B-2.9%	$1.6B-2.1%	$1.6B-1.1%	$1.7B-1.1%	$1.7B+2.8%	$1.7B+1.8%	$1.6B+1.3%
Cash & Equivalents	$15.6M+60.2%	$6.1M-49.0%	$5.0M-50.2%	$5.8M-66.1%	$9.7M-11.6%	$12.0M+78.5%	$10.1M+30.2%	$17.1M+184.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$962.4M+3.5%	$943.6M+0.5%	$916.1M+0.1%	$913.6M+1.9%	$929.7M+1.1%	$939.4M+8.1%	$915.6M+3.5%	$896.2M+0.2%
Long-Term Debt	$922.9M+4.0%	$907.1M+0.5%	$873.8M-0.2%	$875.3M+2.1%	$887.3M+0.8%	$903.0M+8.6%	$875.8M+3.7%	$857.2M+0.1%
Total Equity	$656.5M-9.4%	$674.0M-7.3%	$706.0M-4.7%	$714.1M-4.6%	$724.7M-3.7%	$727.1M-3.3%	$740.6M-0.3%	$748.8M+2.5%
Retained Earnings	-$298.9M-27.5%	-$282.0M-21.6%	-$251.0M-14.9%	-$244.7M-12.7%	-$234.4M-9.8%	-$232.0M-8.3%	-$218.5M+2.2%	-$217.1M-273.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities.

CCAP Cash Flow Statement

CCAP quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	$39.5M	$74.7M+26.8%	$58.9M-36.2%	$92.3M+230.2%	$28.0M+117.7%	-$157.7M-155.1%	-$61.8M
Financing Cash Flow	-$29.8M	-$82.5M-89.9%	-$43.5M+48.9%	-$85.0M-147.0%	-$34.4M-120.7%	$166.3M+163.1%	$63.2M
Dividends Paid	$65.1M	$67.8M-9.9%	$75.2M+16.6%	$64.5M+16.8%	$55.3M+15.8%	$47.7M+12.0%	$42.6M
Share Buybacks	N/A	$1.3M	N/A	N/A	N/A	N/A	$2.2M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$9.8M-73.0%	-$23.8M-57.3%	$22.6M+883.9%	$30.8M-34.4%	$36.4M+247.9%	-$15.1M-138.3%	-$2.9M-108.3%	$46.9M+119.8%
Financing Cash Flow	-$613K+98.5%	$18.8M+195.6%	-$18.9M-480.6%	-$29.1M+35.8%	-$40.9M-242.2%	$6.3M+119.9%	$5.0M+115.1%	-$45.3M-125.9%
Dividends Paid	$16.6M-4.5%	$15.5M-10.9%	$15.6M-14.3%	$17.4M-7.9%	$17.4M-9.6%	$17.4M-7.8%	$18.2M-2.0%	$18.9M+4.1%
Share Buybacks	$667K	$1.0M	$1.0M	N/A	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow.

CCAP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CCAP quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Return on Equity	4.9%-5.1pp	9.9%-1.3pp	11.3%+8.8pp	2.5%-10.3pp	12.8%+3.1pp	9.8%
Return on Assets	2.1%-2.3pp	4.5%-0.7pp	5.1%+4.0pp	1.2%-5.2pp	6.3%	N/A
Debt-to-Equity	1.24+0.1x	1.180.0x	1.14+0.1x	1.07+0.1x	0.97	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Return on Equity	-0.5%-2.6pp	-2.3%-2.8pp	N/A	1.0%-1.1pp	2.1%-0.6pp	0.5%-3.2pp	N/A	2.0%-1.1pp
Return on Assets	-0.2%-1.1pp	-1.0%-1.2pp	N/A	0.4%-0.5pp	0.9%-0.3pp	0.2%-1.5pp	N/A	0.9%-0.5pp
Debt-to-Equity	1.41+0.2x	1.35+0.1x	1.24+0.1x	1.23+0.1x	1.22+0.1x	1.24+0.1x	1.180.0x	1.140.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Crescent Capital BDC, Inc. CCAP	FY2025	N/A	$34.5M	N/A	$364.0M	—
BlackRock TCP Capital Corp. TCPC	FY2025	N/A	-$88.9M	N/A	$336.5M	—
MSC Income Fund, Inc. MSIF	FY2025	N/A	$88.7M	N/A	$558.2M	—

Where Crescent Capital BDC, Inc. Ranks

Frequently Asked Questions

Is Crescent Capital BDC, Inc. profitable?

Yes, Crescent Capital BDC, Inc. (CCAP) reported a net income of $34.5M in fiscal year 2025.

How much debt does Crescent Capital BDC, Inc. have?

As of fiscal year 2025, Crescent Capital BDC, Inc. (CCAP) had $5.0M in cash and equivalents against $873.8M in long-term debt.

What is Crescent Capital BDC, Inc.'s return on equity (ROE)?

Crescent Capital BDC, Inc. (CCAP) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Crescent Capital BDC, Inc.'s operating cash flow?

Crescent Capital BDC, Inc. (CCAP) generated $74.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Crescent Capital BDC, Inc.'s total assets?

Crescent Capital BDC, Inc. (CCAP) had $1.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Crescent Capital BDC, Inc. buy back shares?

Yes, Crescent Capital BDC, Inc. (CCAP) spent $1.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Crescent Capital BDC, Inc. have outstanding?

Crescent Capital BDC, Inc. (CCAP) had 37M shares outstanding as of fiscal year 2025.

What is Crescent Capital BDC, Inc.'s debt-to-equity ratio?

Crescent Capital BDC, Inc. (CCAP) had a debt-to-equity ratio of 1.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Crescent Capital BDC, Inc.'s return on assets (ROA)?

Crescent Capital BDC, Inc. (CCAP) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Crescent Capital BDC, Inc.'s P/E ratio?

Crescent Capital BDC, Inc. (CCAP) trades at 10.5x earnings, its market capitalization divided by net income of $34.5M net income, FY2025. The market capitalization is $364.0M as of Sep 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Crescent Capital BDC, Inc.'s price-to-sales ratio?

Crescent Capital BDC, Inc. (CCAP) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $364.0M as of Sep 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Crescent Capital BDC, Inc.'s Piotroski F-Score?

Crescent Capital BDC, Inc. (CCAP) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Crescent Capital BDC, Inc.'s earnings high quality?

Crescent Capital BDC, Inc. (CCAP) has an earnings quality ratio of 2.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Crescent Capital BDC, Inc. cover its interest payments?

Crescent Capital BDC, Inc. (CCAP) reported an operating loss of $98.7M against $57.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.